×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Ipsen appoints Keira Driansky as EVP, President of North America
Yahoo Finance
PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the...
8 hours ago
Ipsen introduces Ipsen Connect digital gateway to streamline customer service
Metal Additive Manufacturing magazine
Ipsen has announced its digital gateway, Ipsen Connect, intended to simplify access to essential resources, including order history and...
1 day ago
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
PR Newswire
PRNewswire/ -- Ipsen (Euronext: IPN; ADR: IPSEY) and Skyhawk Therapeutics today announced the signing of an exclusive worldwide...
1 week ago
Rx Rundown: Xaira Therapeutics, Ipsen, Sanofi and more
Medical Marketing and Media
Ipsen entered into an RNA research collaboration with Skyhawk Therapeutics that could reach $1.8 billion.
6 days ago
Ipsen, Skyhawk Ink Potential $1.8B Deal to Target RNA in Neuro Diseases
BioSpace
Ipsen is looking to deepen its expertise in movement disorders in a research collaboration with Skyhawk Therapeutics to develop small...
1 week ago
Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D
Fierce Biotech
Ipsen has landed the chance to option two candidates that could benefit from its “neuroscience expertise in movement disorders.”
1 week ago
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance
Ipsen
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance · Total-sales growth greater than 6.0%,...
6 months ago
Ipsen and Skyhawk partner to develop rare neurological therapies
Pharmaceutical Technology
Ipsen has entered an exclusive global collaboration with Skyhawk Therapeutics for the discovery and development of new small molecules that...
1 week ago
Ipsen Expands Its Rare Neurological Disease Pipeline With Skyhawk Deal
Scrip
Deal Snapshot: Ipsen committed up to $1.8bn in upfront and milestone fees to develop novel treatments for rare neurological diseases with Skyhawk's...
1 week ago
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full ...
Yahoo Finance
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its...
1 week ago